Corona Remedies IPO is a book build issue of ₹655.37 crore. The issue is an offer for sale of 0.62 crore shares worth ₹655.37 crore. Bidding for Corona Remedies IPO will open for subscription on December 8, 2025 and will close on December 10, 2025. The allotment of Corona Remedies IPO is expected to be finalized on December 11, 2025. Corona Remedies IPO will be listed on BSE, NSE, with the probable listing date fixed at December 15, 2025. The price band of Corona Remedies IPO has been fixed at ₹1008.00 to ₹1062.00 per share. The lot size for one application is 14. The minimum investment amount required for a retail investor is ₹14,868 (14 shares) (based on cap price). The lot size investment for sNII is 14 lots (196 shares), amounting to ₹2,08,152, and for bNII it is 68 lots (952 shares), amounting to ₹10,11,024. The issue includes reservation of 58,036 shares for employees, which are being offered at a discount of ₹54.00 to the issue price.





























